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ABSTRACT 15 
 16 
Human milk oligosaccharides (HMOs) are considered to play a key role in establishing 17 
and maintaining the infant gut microbiota. Lacto-N-triose forms part of both type 1 and 18 
type 2 HMOs and also of the glycan moieties of glycoproteins. Upstream of the 19 
previously characterized gene cluster involved in lacto-N-biose and galacto-N-biose 20 
metabolism from Lactobacillus casei BL23, there are two genes, bnaG and manA, 21 
encoding for a β-N-acetylglucosaminidase precursor and a mannose-6P isomerase, 22 
respectively. In this work, we have shown that L. casei is able to grow in the presence 23 
of lacto-N-triose as a carbon source. Inactivation of bnaG abolished the growth of L. 24 
casei on this oligosaccharide, demonstrating that BnaG is involved in its metabolism. 25 
Interestingly, whole cells of bnaG mutant are totally devoid of β-N-26 
acetylglucosaminidase activity, suggesting that BnaG is an extracellular wall-attached 27 
enzyme. The purified BnaG enzyme in addition to hydrolyze lacto-N-triose into N-28 
acetylglucosamine and lactose, also catalyzed the hydrolysis of 3’-N-29 
acetylglucosaminyl-mannose and 3’-N-acetylgalactosaminyl-galactose. L. casei can be 30 
cultured in the presence of 3’-N-acetylglucosaminyl-mannose as carbon source but 31 
curiously, the bnaG mutant strain was not impaired in its utilization. These results 32 
indicated that the assimilation of 3’-N-acetylglucosaminyl-mannose was independent of 33 
BnaG. Enzyme activity and growth analysis with a manA knockout mutant showed that 34 
ManA is involved in the utilization of the mannose moiety of 3’-N-acetylglucosaminyl-35 
mannose. This is the first report describing the physiological role of a β-N-36 
acetylglucosaminidase in lactobacilli and it supports the metabolic adaptation of L. 37 
casei to the N-acetylglucosaminide-rich gut niche.   38 
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INTRODUCTION 39 
 40 
Glycans in human milk are present as free oligosaccharides or conjugated bound to 41 
proteins and lipids (1, 2), and they have been proposed to directly influence the 42 
composition of the infant gut microbiota (3, 4). Furthermore, the free human milk 43 
oligosaccharides (HMOs), the third largest solid component in milk, act as prebiotics to 44 
promote colonization by beneficial bacterial species (5, 6). HMOs contain a lactose 45 
moiety (Galβ1-4Glc) at their reducing end, which is elongated by β1,3-linked lacto-N-46 
biose units (Galβ1-3GlcNAc) to give the type 1 HMOs, including lacto-N-tetraose 47 
(Galβ1-3GlcNAcβ1-3Galβ1-4Glc), or by β1,3/6-linked N-acetyllactosamine units 48 
(Galβ1-4GlcNAc) to give the type 2 HMOs, such as lacto-N-neotetraose (Galβ1-49 
4GlcNAcβ1-3Galβ1-4Glc). Further elongation of these core structures is made by the 50 
addition of fucose and sialic acid residues (1). Both types of HMOs contain a lacto-N-51 
triose unit (GlcNAcβ1-3Galβ1-4Glc), highlighting the importance of this trisaccharide in 52 
the total pool of HMOs. In addition, lacto-N-triose and other N-acetylhexosaminyl-53 
oligosaccharides also form part of the structure of glycans conjugated to proteins and 54 
lipids present in human milk. The carbohydrate moieties of these molecules would also 55 
have a prebiotic role, and besides the monosaccharides described above for HMOs 56 
they also contain N-acetylgalactosamine (GalNAc) and mannose (2). 57 
Species belonging to the genera of Bifidobacterium and Lactobacillus are found as 58 
part of the gastrointestinal microbiota of infants (7-9). Specific Bifidobacterium strains 59 
are efficient consumers of HMOs (10), which is in agreement with a large number of 60 
conserved genes with the predicted capacity to hydrolyze those complex glycan 61 
structures (11). This is the case of genes encoding enzymes from the glycoside 62 
hydrolase family 20 (GH20) that comprises lacto-N-biosidases (EC 3.2.1.140) and β-N-63 
acetylhexosaminidases (EC 3.2.1.52). They are endoglycosidases as the lacto-N-64 
biosidase from Bifidobacterium bifidum, that degrades lacto-N-tetraose into lacto-N-65 
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biose and lactose (12), or exoglycosidases with specificity for β(1-2), β(1-3), β(1-4) 66 
and/or β(1-6) glycosidic linkages (13-15). Unlike Bifidobacterium species, data about 67 
the capacity of Lactobacillus species to metabolize human milk and mucosa-associated 68 
glycans are limited. Lactobacillus casei species is commonly isolated from faeces of 69 
breast-fed infants (7, 8). In this work we used L. casei strain BL23 as a laboratory 70 
model because it is easy to manipulate genetically. We have previously characterized 71 
three α-L-fucosidases from this strain (16) and demonstrated that in L. casei species 72 
the utilization of fucosyl-α-1,3-N-acetylglucosamine, an abundant structural 73 
disaccharide present in human milk glycans, is dependent of the specific α-L-74 
fucosidase AlfB  (17). Recently, we have identified in L. casei BL23 the unique 75 
metabolic pathway for both lacto-N-biose and galacto-N-biose (Galβ1-3GalNAc), the 76 
latter is a core structure in mucin glycans. These disaccharides are transported and 77 
phosphorylated by the phosphoenolpyruvate:sugar phosphotransferase system (PTS), 78 
and then they are hydrolyzed into galactose-6P and the corresponding N-79 
acetylhexosamine by the intracellular GH35 phospho-β-galactosidase GnbG (18). A 80 
gene encoding a GH20 β-N-acetylglucosaminidase from L. casei ATCC 27092 has also 81 
been cloned and the purified enzyme has been biochemically characterized (19), but 82 
neither natural substrates were tested nor was its physiological role determined for this 83 
enzyme. In this work we demonstrated that L. casei BL23 is able to grow in the 84 
presence of lacto-N-triose. The chromosomal inactivation of the bnaG gene, encoding 85 
an extracellular β-N-acetylglucosaminidase, prevented the growth on this carbohydrate, 86 
revealing for the first time the physiological role of a β-N-acetylglucosaminidase from 87 
Lactobacillus. Additionally, we showed that 3’-N-acetylglucosaminyl-mannose is also a 88 
fermentable carbon source for L. casei and that a mutant for manA, encoding a 89 
mannose-6P isomerase, is involved in its metabolism.   90 
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MATERIALS AND METHODS 91 
 92 
Bacterial strains, culture conditions and plasmids. The strains and plasmids 93 
used in this study are listed in Table 1. The Lactobacillus casei strains were routinely 94 
grown at 37ºC under static conditions on MRS medium (Difco). Escherichia coli, which 95 
was used as host in cloning experiments, was grown in Luria-Bertani medium at 37ºC 96 
(Oxoid). The corresponding solid media were prepared by adding 1.8 % agar. E. coli 97 
DH10B transformants were selected with ampicillin (100 μg/ml) and E. coli BE50 with 98 
ampicillin (100 μg/ml) and kanamycin (25 μg/ml). L. casei transformants were selected 99 
with erythromycin (5 μg/ml). 100 
Vector pRV300 (20) was used for cloning experiments with E. coli and for 101 
insertional inactivation of genes in L. casei. Vector pQE80 (Qiagen) was used for 102 
protein overproduction. E. coli and L. casei strains were transformed by electroporation 103 
with a Gene Pulser apparatus (Bio-Rad Laboratories) as recommended by the 104 
manufacturer (E. coli) or as described earlier (L. casei) (21). 105 
 106 
Culture of L. casei strains with oligosaccharides. The L. casei strains  were 107 
grown overnight at 37ºC under static conditions on sugar-free MRS fermentation 108 
medium (18). Overnight cultures were diluted to an OD550 of 0.05 in 100 μl of MRS 109 
medium containing 2 mM of lacto-N-neotetraose, lacto-N-triose, 3’-N-110 
acetylglucosaminyl-mannose, 3’-N-acetylgalactosaminyl-galactose, lactose, N-111 
acetylglucosamine or mannose. The first four oligosaccharides were obtained from 112 
Carbosynth (Compton, Berkshire, UK). Bacterial growth was monitored for 24 h by 113 
spectrophotometric measurements every 30 min at 550 nm in 96-well plates at 37ºC 114 
without shaking in a POLARstar Omega microplate reader (BMG Labtech, Offenburg, 115 
Germany). At least three independent biological replicates for each growth curve were 116 
obtained. Results were expressed as means ± standard deviations. The growth rates 117 
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(μ) were calculated by using the Gompertz model (Graph Pad Software, San Diego, 118 
CA, USA). 119 
 120 
DNA manipulation and sequencing. Total DNA was isolated from L. casei BL23 121 
as described before (21). Recombinant DNA techniques were performed by following 122 
standard procedures (22). All PCR reactions were performed with the Expand High 123 
Fidelity PCR System (Roche). DNA sequencing was carried out by the Central Service 124 
of Research Support of the University of Valencia (Spain). M13 universal and reverse 125 
primers or custom primers hybridizing within the appropriate DNA fragments were used 126 
for sequencing. Sequence analyses were carried out with DNAMAN 4.03 for Windows 127 
(Lynnon BioSoft) and sequence similarities were analyzed with the BLAST program 128 
(23). 129 
 130 
Construction of recombinant strains. DNA fragments containing part of bnaG and 131 
manA were obtained by PCR using L. casei BL23 chromosomal DNA and the 132 
oligonucleotides pairs: BnaGFow (5’-AGCTGCTGCTGATAACACC)/BnaGRev (5’-133 
TCGGCTGGGCGAACTAAG) and ManAFow (5’-TTCATAGTGTCACGCAAGG)/ManA 134 
Rev (5’-TGAACGTCATGGTGCCATC), respectively. The PCR products were cloned 135 
into pRV300 digested with EcoRV. The resulting plasmids pRVbnaG and pRVmanA 136 
were cleaved at the unique SphI and XagI restriction sites present in the bnaG and 137 
manA coding regions, respectively. The two digested plasmids were then treated with 138 
the Klenow fragment of DNA polymerase I, ligated and transformed. Different 139 
constructs were selected in which a frameshift was introduced at the SphI and XagI 140 
sites in bnaG (pRVbnaG) and manA (pRVmanA), respectively. L. casei was 141 
transformed with each of these plasmids and one erythromycin-resistant clone of each 142 
gene carrying the plasmid integrated by single cross-over was grown in MRS without 143 
erythromycin for about 200 generations. Cells were plated on MRS and replica plated 144 
on MRS plus erythromycin. Antibiotic-sensitive clones were isolated and, among them, 145 
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one for each gene was selected (BL380 and BL381 strains) in which a second 146 
recombination event led to the excision of the plasmid leaving a mutated bnaG and 147 
manA copy, respectively, as was confirmed by sequence analysis of appropriate PCR 148 
products. 149 
 150 
Oligosaccharide and monosaccharide analysis. To determine the carbohydrates 151 
present in the supernatants from the L. casei cultures, the cells were removed by 152 
centrifugation and the cultures were analyzed by high-performance liquid 153 
chromatography (HPLC) using a Jasco PU2080Plus system (L. casei cultures on lacto-154 
N-neotetraose, lacto-N-triose, 3’-N-acetylgalactosaminyl-galactose or lactose) or an 155 
ICS3000 chromatographic system (Dionex) (L. casei cultures on 3’-N-156 
acetylglucosaminyl-mannose or mannose). The PU2080Plus system was coupled to a 157 
refractive index detector (Jasco RI-2031 Plus) using a Rezex RCM-Monosaccharide 158 
column (Phenomenex). The column was kept at 80ºC and the samples were eluted in 159 
isocratic mode using water as the mobile phase at a flow rate of 0.6 ml/min. For the 160 
Dionex system, with pulsed amperometric detection, a CarboPac PA100 column was 161 
used. A combined gradient of 100 to 300 mM NaOH and 0 to 300 mM acetic acid was 162 
used (100 mM NaOH during 2 min; 100 to 300 mM NaOH during 3 min; 300 mM NaOH 163 
and 0 to 300 mM acetic acid during 15 min) at a flow rate of 1 ml/min. Oligo- and 164 
monosaccharides were confirmed by comparison of their retention times with those of 165 
standards (glucose, galactose, GlcNAc, GalNAc, mannose, fructose and the di, tri and 166 
tetrasaccharides listed in Table 3).   167 
 168 
BnaG enzyme activity in whole cells and supernatants of L. casei cultures. The 169 
L. casei strains were grown overnight at 37ºC under static conditions on 10 ml of MRS 170 
fermentation medium containing 0.5 % glucose or 0.5 % ribose. When the cultures 171 
reached an OD550 of 1.5 (glucose) or 1.2 (ribose), cells were collected by centrifugation 172 
at 8000 x g for 10 min, and the supernatants were subject to ultracentrifugation at 173 
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100000 x g for 60 min to remove cell debris. The cell pellets washed twice with 174 
phosphate buffered saline (PBS) and resuspended in this buffer to an OD550 of 2. The 175 
BnaG enzyme activity was determined at 37ºC with 2.5 mM 4-nitrophenyl (NP)-N-176 
acetyl-β-D-glucosaminide (pNPGlcNAc) in 96-well plates. The 4-nitrophenol released 177 
was measured by following continuous changes in absorbance at 404 nm using a 178 
POLARstar Omega microplate reader (BMG Labtech, Offenburg, Germany). Reaction 179 
mixtures (100 μl) containing the substrate in 100 mM sodium phosphate buffer pH 6.5, 180 
were initiated by adding 75 μl of cell suspension or culture supernatant. 181 
 182 
Expression and purification of His-tagged BnaG and ManA. The coding regions 183 
of bnaG and manA were amplified by PCR using chromosomal DNA from L. casei 184 
BL23 as template and the primers pairs: 2860BamHIFW (5’-TTTTGGATC 185 
CGCTGATAACACCTTGAAAAGCG)/2860HindIIIRV (5’-TTTTAAGCTTTTACCGGTCT 186 
GGATTCACAATGG) and 2870BamHIFW (5’-TTTTGGATCCTTGACAGAACCATTATT 187 
TTTAAAACC)/2870HindIIIRV (5’-TTTTAAGCTTTTATGCGTCTACCCCTGGAGTAG), 188 
respectively, with added restriction sites to the 5´- and 3´-ends (underlined). The PCR 189 
fragments were cleaved with the corresponding restriction enzymes and cloned into 190 
pQE80 digested with the same enzymes. The resulting plasmids pQEbnaG and 191 
pQEmanA were used to transform E. coli BE50, and the correct sequence of the 192 
inserts was confirmed by DNA sequencing. One clone of each, PE168 (pQEbnaG) and 193 
PE169 (pQEmanA), was grown in 0.5 l Luria-Bertani medium with appropriate 194 
antibiotics at 20ºC under agitation. When the cultures reach an OD550 of 1.0, IPTG (1 195 
mM) was added and incubation was continued for 5 h. Cells were harvested by 196 
centrifugation and resuspended in lysis buffer (Tris·HCl 50 mM pH 7.5, NaCl 100 mM, 197 
Na2SO4 50 mM, dithiothreitol 0.5 mM and phenylmethysulfonyl fluoride 1mM). The 198 
recombinant proteins were purified as described previously (18). Fractions containing 199 
the proteins of interest were analysed by SDS-PAGE gels, pooled, dialysed against 200 
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Tris·HCl 100 mM, pH 7.5, containing 20% glycerol and kept frozen at –80ºC. Protein 201 
concentrations were determined by spectrophotometric measurements at 280 nm in a 202 
NanoDrop Instrument (Thermo Scientific, Wilmington, USA). 203 
 204 
His-tagged BnaG enzyme activity. The activity of the purified His-tagged BnaG 205 
enzyme was assayed at 37ºC with different 2/4-NP-sugars (Table 2) at 5 mM in 96-well 206 
plates. The 2/4-nitrophenol released was measured by following continuous changes in 207 
absorbance at 404 nm using a POLARstar Omega microplate reader (BMG Labtech, 208 
Offenburg, Germany). Reaction mixtures (100 μl) containing the substrate in 100 mM 209 
Tris-HCl buffer, pH7.0, were initiated by adding 1 μg of enzyme. The optimal pH was 210 
determined with 5 mM pNPGlcNAc using 100 mM phosphate-citrate buffer, (pH 3.0 to 211 
7.0) and 100 mM glycine-NaOH buffer (pH 7.5 to 9.5). The optimal temperature 212 
reaction was analysed in a range from 20 to 60ºC at the optimal pH. Kinetic studies 213 
were performed in 100 mM Tris-HCl buffer, pH 7.0, at 37ºC with 4 pNPGlcNAc ranging 214 
from 0.5 to 7.5 mM.  215 
In order to determine the ability of BnaG to hydrolyse natural oligosaccharides, 216 
several substrates were tested (Table 2). The reactions (100 μl) were performed at 217 
37ºC for 16 h using 4mM substrate in 100 mM Tris-HCl buffer, pH7.0. The reaction 218 
mixtures were analysed by HPLC using the Jasco PU2080Plus system as described 219 
above. 220 
 221 
His-tagged ManA enzyme activity. The activity of the purified His-tagged ManA 222 
enzyme was assayed as previously described (24) with some modifications. A typical 223 
reaction mixture (100 μl) contained 50 mM Tris-HCl buffer, pH 8.0, 5 mM MgCl2, 1 mM 224 
NADP+, 0.5 U of phosphoglucose isomerase, 1.0 U of glucose-6P dehydrogenase and 225 
3 mM mannose-6P. The reactions were initiated by adding 2 μg of enzyme. The activity 226 
was assayed at 37ºC in 96-well plates and the NADPH formation was monitored by 227 
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following continuous changes in absorbance at 340 nm using a POLARstar Omega 228 
microplate reader (BMG Labtech, Offenburg, Germany). Kinetic studies were 229 
performed with mannose-6 P concentrations ranging from 1.0 to 10 mM.  230 
 231 
Nucleotide sequence accession numbers. The sequences of the truncated genes 232 
were deposited in GenBank under accession numbers KT954009 and KT954010. 233 
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RESULTS AND DISCUSSION 234 
 235 
L. casei β-N-acetylglucosaminidase BnaG is an extracellular wall-attached 236 
protein. Analysis of the genome surroundings of the gnb operon, which is involved in 237 
the utilization of lacto-N-biose and galacto-N-biose in L. casei BL23 (18), revealed the 238 
presence of two genes, one named here as bnaG (LCABL_02860) and manA 239 
(LCABL_02870) that are annotated as a putative β-N-acetylglucosaminidase precursor 240 
and a putative mannose-6P isomerase, respectively (Fig. 1A). The deduced amino acid 241 
sequence of bnaG showed a conserved protein domain GH20_DspB_LnbB-like 242 
(cd06564), ranging from amino acids 38 to 377 (25). Sequence analysis using SignalP-243 
4.0 (http://www.cbs.dtu.dk) additionally showed that BnaG displayed an N-terminal 244 
signal peptide for secretion (amino acids 1 to 32), and a predicted C-terminal sortase-245 
dependent cell wall-anchoring domain (amino acids 533 to 569) was already described 246 
(26). In order to determine if the bnaG gene was responsible of the β-N-247 
acetylglucosaminidase activity in whole cells of L. casei BL23 (26), a mutant in bnaG 248 
was constructed (strain BL380). The results showed that in the wild-type the activity 249 
was higher in ribose than in glucose grown cells (Table 2), confirming previous studies 250 
that showed that the β-N-acetylglucosaminidase activity in L. casei was subjected to 251 
catabolic repression by glucose (27). β-N-acetylglucosaminidase activity was also 252 
found in the supernatants of BL23 strain (Table 2), suggesting that part of the enzyme 253 
is liberated as a free enzyme to the culture medium. Interestingly, whole cells and 254 
supernatants of the BL380 mutant are totally devoid of activity (Table 2), indicating that 255 
bnaG gene is responsible of the β-N-acetylglucosaminidase activity present in L. casei. 256 
 257 
Substrate specificity and enzymatic characteristics of L. casei β-N-258 
acetylglucosaminidase BnaG. The His-tagged β-N-acetylglucosaminidase BnaG 259 
from L. casei without the N-terminal signal peptide and the C-terminal cell wall-260 
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anchoring domain was expressed in E. coli. The purified protein showed a molecular 261 
weight of 55 kDa, in agreement with the calculated mass of the 6x(His)-tagged protein 262 
(55.250 Da; Fig. 2). The recombinant BnaG hydrolyzed pNPGlcNAc and 2-NP-β-D-263 
galactopyranoside, however the latter was poorly hydrolyzed (Table 3). The catalytic 264 
properties of BnaG using pNPGlcNAc as substrate were determined (Table 3). 265 
Although the deduced amino acid sequences of BnaG and the N-266 
acetylglucosaminidase from L. casei ATCC 27092 (19) showed high homology (91.7 % 267 
identity), the Km, optimum pH and temperature were different. The Km (6.4 μM) of the 268 
enzyme from the ATCC 27092 strain showed that the affinity for the substrate 269 
pNPGlcNAc was about 350-fold higher than that of BnaG. The modifications of the 270 
sequence described above for the purified BnaG could account for those differences 271 
between both β-N-acetylglucosaminidases. Indeed, the enzyme from the ATCC 27092 272 
strain showed a lower molecular weight (39 kDa) (19) than that determined for BnaG. 273 
Regarding natural oligosaccharides, BnaG is able to degrade lacto-N-triose into 274 
GlcNAc and lactose. However, it does not hydrolyze lacto-N-tetraose or lacto-N-275 
neotetraose, which contain the same GlcNAcβ1,3-glycosidic linkage, indicating that 276 
BnaG showed exoglycosidase but not endoglycosidase activity. BnaG degrades also 277 
the disaccharides 3’-N-Acetylglucosaminyl-mannose, 3’-N-Acetylgalactosaminyl-278 
galactose, galacto-N-biose and lacto-N-biose, although the last two were cleaved very 279 
inefficiently (Table 3). These results indicated that the β-N-acetylglucosaminidase 280 
BnaG from L. casei showed specificity for β1,3-glycosidic linkages, and within these N-281 
Acetylhexosaminyl-β1,3-linked sugars are better substrates than their corresponding 282 
hexoses. 283 
   284 
L. casei ferments lacto-N-triose and hydrolyzes it by using the β-N-acetyl-285 
glucosaminidase BnaG. In order to determine the capacity of L. casei BL23 to 286 
metabolize lacto-N-triose, 3’-N-acetylglucosaminyl-mannose and 3’-N-287 
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acetylgalactosaminyl-galactose, which were substrates in vitro for the β-N-acetyl-288 
glucosaminidase BnaG, the growth profile in MRS basal medium supplemented with 2 289 
mM of those oligosaccharides was determined independently. L. casei BL23 was able 290 
to grow in the presence of lacto-N-triose and 3’-N-Acetylglucosaminyl-mannose, 291 
respectively, as fermentable carbon sources (Fig. 3A). However, the presence of 3’-N-292 
acetylgalactosaminyl-galactose resulted in a diminished growth, compared with the 293 
residual growth of L. casei in non-supplemented MRS basal medium (Fig. 3A). The 294 
growth pattern of L. casei in the presence of lactose as a positive control is also shown 295 
(Fig. 3A). To determine if the β-N-acetyl-glucosaminidase BnaG was involved in the 296 
utilization of lacto-N-triose and 3’-N-acetylglucosaminyl-mannose in L. casei BL23, the 297 
mutant strain BL380 (bnaG) was cultured in the presence of those oligosaccharides, 298 
respectively, as carbon sources. Interestingly, this mutant exhibited a diminished 299 
growth with lacto-N-triose which was comparable to that of the negative control (non-300 
supplemented MRS basal medium), indicating that BnaG is necessary for the utilization 301 
of this oligosaccharide (Fig. 3B). Sugar content analysis of the culture supernatants 302 
detected lacto-N-triose in the supernatants from BL380 (bnaG), while it was completely 303 
consumed by the wild-type BL23 strain. In the wild type strain, the resulting products 304 
(GlcNAc and lactose) from the lacto-N-triose hydrolysis by BnaG were also exhausted. 305 
The above results suggested that BnaG is an extracellular enzyme, and then it will 306 
hydrolyze lacto-N-triose outside the cells into GlcNAc and lactose. GlcNAc would be 307 
then transported inside the cells by a yet unknown PTS and/or a PTS-independent 308 
permease (28). The lactose moiety would be internalized by the already characterized 309 
PTSLac into the cells as lactose-6P, and this phosphorylated sugar will be degraded by 310 
the phospho-β-galactosidase LacG into galactose-6P and glucose (29) (Fig. 1B). 311 
Although 3’-N-Acetylglucosaminyl-mannose is an in vitro substrate for BnaG, the 312 
results showed that the growth rate (0.120 h-1) of BL380 (bnaG) is similar to the rate of 313 
the wild-type (0.113 h-1) (Fig. 3B), suggesting that its metabolism is independent of that 314 
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glycosidase. Sugar content analysis of the culture supernatants did not detect 3’-N-315 
Acetylglucosaminyl-mannose either in BL23 or BL380 culture supernatants. 316 
The metabolism of lacto-N-triose resulting from the catabolism of lacto-N-317 
neotetraose has been previously reported in B. bifidum (13). This tetra-saccharide was 318 
sequentially hydrolyzed from its non-reducing terminus by two extracellular exo-319 
enzymes, with β-galactosidase and β-N-acetylglucosaminidase activity, respectively 320 
(13). L. casei is able to grow in the presence of lacto-N-triose, whereas it was not able 321 
to ferment lacto-N-neotetraose (data not shown), suggesting that this strain lacks a β-322 
galactosidase activity able to convert the tetra-saccharide into galactose and lacto-N-323 
triose, at least under our experimental conditions. Analysis of the available genome 324 
sequences of lactobacilli (http://www.ncbi.nlm.nih.gov/genomes) showed that the bnaG 325 
gene was only present in the L. casei and Lactobacillus paracasei species. Notably, it 326 
was not conserved in the phylogenetically related Lactobacillus rhamnosus species. 327 
The lack of bnaG gene in these latter species correlated with the inability of two strains 328 
of L. rhamnosus (strains ATCC 9595 and ATCC 53103 [GG]) to metabolize lacto-N-329 
triose. However, L. rhamnosus strain HN001 was able to grow using lacto-N-triose as 330 
carbon source (G. N. Bidart, J. Rodríguez-Díaz and M.J. Yebra, unpublished results), 331 
suggesting that in addition to BnaG, lactobacilli have other enzymes involved in the 332 
catabolism of this tri-saccharide.  333 
 334 
ManA is required for mannose and 3’-N-Acetylglucosaminyl-mannose 335 
metabolism in L. casei. As shown above 3’-N-Acetylglucosaminyl-mannose was a 336 
carbon source for L. casei BL23, and a mutant deficient in the general component 337 
enzyme I of the PTS (28) was unable to ferment that disaccharide, which remained 338 
non-hydrolyzed in the culture supernatant (data not shown). These results suggest that 339 
3’-N-Acetylglucosaminyl-mannose is transported and phosphorylated by the PTS and it 340 
might be hydrolyzed inside the cells by a yet unknown phospho-β-glycosidase (Fig. 341 
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1B). The PTS phosphorylates the incoming disaccharides at the non-reducing end (18, 342 
29), therefore the intracellular products generated from 3’-N-Acetylglucosaminyl-343 
mannose would probably be GlcNAc-P and mannose. We analyzed if the manA gene 344 
was involved in the metabolism of that disaccharide. The deduced amino acid 345 
sequence of manA showed a 53 % and 48 % identity with the characterized type I 346 
mannose-6P isomerase (EC.5.3.1.8) from Streptococcus mutans (30) and Bacillus 347 
subtilis (31), respectively. The manA gene from L. casei BL23 codes for a 323 amino 348 
acids protein, without a signal peptide or a cell wall-anchoring motif, and it was 349 
expressed in E. coli. The purified His-tagged protein showed a molecular weight of 37 350 
kDa, in agreement with the calculated mass of the 6x(His)-tagged protein (36.815 Da; 351 
Fig. 2). The ManA activity was analyzed by following the conversion of mannose-6P 352 
into fructose-6P and it exhibited a Vmax of 1.11 μmol/mg protein/min and a Km of 2.78 353 
mM. This and the results presented below also suggested that the mannose resulting 354 
from the hydrolysis of 3’-N-Acetylglucosaminyl-mannose would be phosphorylated by a 355 
mannose kinase at the C-6 position. Mannose-6P will be converted into the glycolytic 356 
intermediary fructose-6P by ManA (Fig. 1B). 357 
To determine if the mannose-6P isomerase ManA was involved in the utilization of 358 
3’-N-Acetylglucosaminyl-mannose in L. casei BL23, a mutant in manA was constructed 359 
(strain BL381). Interestingly, this mutant showed a growth rate (0.064 h-1) lower than 360 
the wild-type strain BL23 (0.113 h-1) with that disaccharide as carbon source in the 361 
culture medium (Fig. 4), indicating that manA is involved in the utilization of 3’-N-362 
Acetylglucosaminyl-mannose. However, mannose was not detected in the culture 363 
supernatants from BL381, which is in agreement with the fact that the maximum cell 364 
density reached by this strain was similar to that of the wild-type BL23. The growth of 365 
strain BL381 (manA) with mannose as carbon source was lower (0.026 h-1) to that of 366 
the negative control (non-supplemented MRS basal medium) (0.038 h-1) (Fig. 4B), 367 
indicating that ManA is necessary for the utilization of mannose in L. casei. Curiously, 368 
after 24 h the culture reached an OD similar to that of the control, which indicates that 369 
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BL381 growth is recovering. These results and the growth profile of BL381 strain in the 370 
presence of 3’-N-Acetylglucosaminyl-mannose suggested that additional genes 371 
involved in the metabolism of the mannose might be expressed. Using the deduced 372 
amino acid sequence of ManA in BLAST searches against the L. casei BL23 genome 373 
(32), another mannose-6P isomerase was found (LCABL_06290). It showed a 47 % 374 
homology (30 % identity) with the ManA characterized here. Hence, the catabolism of 375 
3’-N-Acetylglucosaminyl-mannose in the manA mutant might depend on this additional 376 
mannose-6P isomerase able to utilize the mannose-6P generated.  377 
Lactobacillus casei species is associated with the infant and adult human 378 
gastrointestinal tract and some strains are considered beneficial for the host (7, 8, 33). 379 
The establishment of this species in the gut and its interaction with the host will rely on 380 
its nutritional capacities. The extracellular localization of the β-N-acetylglucosaminidase 381 
study here and its activity on human milk and mucosa-linked glycans probably 382 
constitute a molecular strategy of these bacteria to survive in the gut.   383 
 17 
 
ACKNOWLEDGEMENTS 384 
 385 
This work was financed by funds of the Spanish Ministry for Economy and 386 
Competitiveness (MINECO)/FEDER through the Projects AGL2014-52996-C2 (1-R and 387 
2-R), and of the Valencian Government through project ACOMP/2012/030. G.N.B. was 388 
supported by a predoctoral fellowship from the Carolina Foundation and Argentinian 389 
Ministry of Education.   390 
 18 
 
REFERENCES 391 
 392 
1. Bode L. 2012. Human milk oligosaccharides: every baby needs a sugar mama. 393 
Glycobiology 22:1147-1162. 394 
2. Garrido D, Dallas DC, Mills DA. 2013. Consumption of human milk 395 
glycoconjugates by infant-associated bifidobacteria: mechanisms and 396 
implications. Microbiology 159:649-664. 397 
3. Wang M, Li M, Wu S, Lebrilla CB, Chapkin RS, Ivanov I, Donovan SM. 398 
2015. Fecal microbiota composition of breast-fed infants is correlated with 399 
human milk oligosaccharides consumed. J Pediatr Gastroenterol Nutr 60:825-400 
833. 401 
4. De Leoz ML, Kalanetra KM, Bokulich NA, Strum JS, Underwood MA, 402 
German JB, Mills DA, Lebrilla CB. 2015. Human milk glycomics and gut 403 
microbial genomics in infant feces show a correlation between human milk 404 
oligosaccharides and gut microbiota: a proof-of-concept study. J Proteome Res 405 
14:491-502. 406 
5. Yu ZT, Chen C, Kling DE, Liu B, McCoy JM, Merighi M, Heidtman M, 407 
Newburg DS. 2013. The principal fucosylated oligosaccharides of human milk 408 
exhibit prebiotic properties on cultured infant microbiota. Glycobiology 23:169-409 
177. 410 
6. Li M, Monaco MH, Wang M, Comstock SS, Kuhlenschmidt TB, Fahey GC, 411 
Jr., Miller MJ, Kuhlenschmidt MS, Donovan SM. 2014. Human milk 412 
oligosaccharides shorten rotavirus-induced diarrhea and modulate piglet 413 
mucosal immunity and colonic microbiota. ISME J 8:1609-1620. 414 
7. Martin R, Heilig GH, Zoetendal EG, Smidt H, Rodriguez JM. 2007. Diversity 415 
of the Lactobacillus group in breast milk and vagina of healthy women and 416 
potential role in the colonization of the infant gut. J Appl Microbiol 103:2638-417 
2644. 418 
8. Albesharat R, Ehrmann MA, Korakli M, Yazaji S, Vogel RF. 2011. 419 
Phenotypic and genotypic analyses of lactic acid bacteria in local fermented 420 
food, breast milk and faeces of mothers and their babies. Syst Appl Microbiol 421 
34:148-155. 422 
9. Turroni F, Peano C, Pass DA, Foroni E, Severgnini M, Claesson MJ, Kerr 423 
C, Hourihane J, Murray D, Fuligni F, Gueimonde M, Margolles A, De Bellis 424 
G, O'Toole PW, van Sinderen D, Marchesi JR, Ventura M. 2012. Diversity of 425 
bifidobacteria within the infant gut microbiota. PLoS One 7:e36957. 426 
 19 
 
10. Locascio RG, Ninonuevo MR, Kronewitter SR, Freeman SL, German JB, 427 
Lebrilla CB, Mills DA. 2009. A versatile and scalable strategy for glycoprofiling 428 
bifidobacterial consumption of human milk oligosaccharides. Microb Biotechnol 429 
2:333-342. 430 
11. LoCascio RG, Desai P, Sela DA, Weimer B, Mills DA. 2010. Broad 431 
conservation of milk utilization genes in Bifidobacterium longum subsp. infantis 432 
as revealed by comparative genomic hybridization. Appl Environ Microbiol 433 
76:7373-7381. 434 
12. Wada J, Ando T, Kiyohara M, Ashida H, Kitaoka M, Yamaguchi M, 435 
Kumagai H, Katayama T, Yamamoto K. 2008. Bifidobacterium bifidum lacto-436 
N-biosidase, a critical enzyme for the degradation of human milk 437 
oligosaccharides with a type 1 structure. Appl Environ Microbiol 74:3996-4004. 438 
13. Miwa M, Horimoto T, Kiyohara M, Katayama T, Kitaoka M, Ashida H, 439 
Yamamoto K. 2010. Cooperation of beta-galactosidase and beta-N-440 
acetylhexosaminidase from bifidobacteria in assimilation of human milk 441 
oligosaccharides with type 2 structure. Glycobiology 20:1402-1409. 442 
14. Jiang YL, Yu WL, Zhang JW, Frolet C, Di Guilmi AM, Zhou CZ, Vernet T, 443 
Chen Y. 2011. Structural basis for the substrate specificity of a novel beta-N-444 
acetylhexosaminidase StrH protein from Streptococcus pneumoniae R6. J Biol 445 
Chem 286:43004-43012. 446 
15. Thi NN, Offen WA, Shareck F, Davies GJ, Doucet N. 2014. Structure and 447 
activity of the Streptomyces coelicolor A3(2) beta-N-acetylhexosaminidase 448 
provides further insight into GH20 family catalysis and inhibition. Biochemistry 449 
53:1789-1800. 450 
16. Rodriguez-Diaz J, Monedero V, Yebra MJ. 2011. Utilization of natural 451 
fucosylated oligosaccharides by three novel alpha-L-fucosidases from a 452 
probiotic Lactobacillus casei strain. Appl Environ Microbiol 77:703-705. 453 
17. Rodriguez-Diaz J, Rubio-del-Campo A, Yebra MJ. 2012. Lactobacillus casei 454 
ferments the N-Acetylglucosamine moiety of fucosyl-alpha-1,3-N-455 
acetylglucosamine and excretes L-fucose. Appl Environ Microbiol 78:4613-456 
4619. 457 
18. Bidart GN, Rodriguez-Diaz J, Monedero V, Yebra MJ. 2014. A unique gene 458 
cluster for the utilization of the mucosal and human milk-associated glycans 459 
galacto-N-biose and lacto-N-biose in Lactobacillus casei. Mol Microbiol 93:521-460 
538. 461 
19. Senba M, Kashige N, Nakashima Y, Miake F, Watanabe K. 2000. Cloning of 462 
the gene of beta-N-acetylglucosaminidase from Lactobacillus casei ATCC 463 
 20 
 
27092 and characterization of the enzyme expressed in Escherichia coli. Biol 464 
Pharm Bull 23:527-531. 465 
20. Leloup L, Ehrlich SD, Zagorec M, Morel-Deville F. 1997. Single-crossover 466 
integration in the Lactobacillus sake chromosome and insertional inactivation of 467 
the ptsI and lacL genes. Appl Environ Microbiol 63:2117-2123. 468 
21. Posno M, Leer RJ, van Luijk N, van Giezen MJ, Heuvelmans PT, Lokman 469 
BC, Pouwels PH. 1991. Incompatibility of Lactobacillus Vectors with Replicons 470 
Derived from Small Cryptic Lactobacillus Plasmids and Segregational Instability 471 
of the Introduced Vectors. Appl Environ Microbiol 57:1822-1828. 472 
22. Sambrook J, E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a 473 
laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring 474 
Harbor, NY. 475 
23. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. 1990. Basic local 476 
alignment search tool. J Mol Biol 215:403-410. 477 
24. Gill JF, Deretic V, Chakrabarty AM. 1986. Overproduction and assay of 478 
Pseudomonas aeruginosa phosphomannose isomerase. J Bacteriol 167:611-479 
615. 480 
25. Marchler-Bauer A, Derbyshire MK, Gonzales NR, Lu S, Chitsaz F, Geer LY, 481 
Geer RC, He J, Gwadz M, Hurwitz DI, Lanczycki CJ, Lu F, Marchler GH, 482 
Song JS, Thanki N, Wang Z, Yamashita RA, Zhang D, Zheng C, Bryant SH. 483 
2015. CDD: NCBI's conserved domain database. Nucleic Acids Res 43:D222-484 
226. 485 
26. Munoz-Provencio D, Rodriguez-Diaz J, Collado MC, Langella P, Bermudez-486 
Humaran LG, Monedero V. 2012. Functional analysis of the Lactobacillus 487 
casei BL23 sortases. Appl Environ Microbiol 78:8684-8693. 488 
27. Monedero V, Gosalbes MJ, Perez-Martinez G. 1997. Catabolite repression in 489 
Lactobacillus casei ATCC 393 is mediated by CcpA. J Bacteriol 179:6657-6664. 490 
28. Viana R, Monedero V, Dossonnet V, Vadeboncoeur C, Perez-Martinez G, 491 
Deutscher J. 2000. Enzyme I and HPr from Lactobacillus casei: their role in 492 
sugar transport, carbon catabolite repression and inducer exclusion. Mol 493 
Microbiol 36:570-584. 494 
29. Gosalbes MJ, Monedero V, Alpert CA, Perez-Martinez G. 1997. Establishing 495 
a model to study the regulation of the lactose operon in Lactobacillus casei. 496 
FEMS Microbiol Lett 148:83-89. 497 
30. Sato Y, Yamamoto Y, Kizaki H, Kuramitsu HK. 1993. Isolation and sequence 498 
analysis of the pmi gene encoding phosphomannose isomerase of 499 
Streptococcus mutans. FEMS Microbiol Lett 114:61-66. 500 
 21 
 
31. Yeom SJ, Ji JH, Kim NH, Park CS, Oh DK. 2009. Substrate specificity of a 501 
mannose-6-phosphate isomerase from Bacillus subtilis and its application in the 502 
production of L-ribose. Appl Environ Microbiol 75:4705-4710. 503 
32. Maze A, Boel G, Zuniga M, Bourand A, Loux V, Yebra MJ, Monedero V, 504 
Correia K, Jacques N, Beaufils S, Poncet S, Joyet P, Milohanic E, 505 
Casaregola S, Auffray Y, Perez-Martinez G, Gibrat JF, Zagorec M, Francke 506 
C, Hartke A, Deutscher J. 2010. Complete genome sequence of the probiotic 507 
Lactobacillus casei strain BL23. J Bacteriol 192:2647-2648. 508 
33. Turroni F, Ventura M, Butto LF, Duranti S, O'Toole PW, Motherway MO, 509 
van Sinderen D. 2014. Molecular dialogue between the human gut microbiota 510 
and the host: a Lactobacillus and Bifidobacterium perspective. Cell Mol Life Sci 511 
71:183-203. 512 
34. Dale GE, Schonfeld HJ, Langen H, Stieger M. 1994. Increased solubility of 513 
trimethoprim-resistant type S1 DHFR from Staphylococcus aureus in 514 
Escherichia coli cells overproducing the chaperonins GroEL and GroES. Protein 515 
Eng 7:925-931. 516 
 517 
   518 
 22 
 
TABLE 1. Strains and plasmids used in this studya 519 
Strain or plasmid Relevant genotype or properties Source or 
referencea
Strains   
Lactobacillus casei   
BL23 Wild type CECT 5275 
BL126 BL23 ptsI  (28) 
BL380 BL23 bnaG (frameshift at SphI site) This work 
BL381 BL23 manA (frameshift at XagI site) This work 
Escherichia coli   
DH10B F- endA1 recA1 galE15 galK16 nupG rpsL 
ΔlacX74 Φ80lacZΔM15 araD139 
Invitrogen 
BE50 BL21(DE3) containing pREPGroES/GroEL (34) 
PE168 BE50 containing pQEbnaG  This work 
PE169 BE50 containing pQEmanA  This work 
  
Plasmids   
pRV300 Suicide vector carrying ErmR from pAMβ1 (20) 
pRVbnaG pRV300 with a frameshift at SphI site in bnaG  This work 
pRVmanA pRV300 with a frameshift at XagI site in manA This work 
pQE80 E. coli expression vector; AmpR Qiagen 
pQE bnaG pQE80 containing bnaG-coding region This work 
pQEmanA pQE80 containing manA-coding region This work 
aCECT, Colección Española de Cultivos Tipo; ErmR, erythromycin resistance; AmpR, 520 
ampicillin resistant.  521 
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TABLE 2. N-acetylglucosaminidase activity in whole cells and 522 
supernatants of L. casei cultured in MRS fermentation medium with 523 
glucose or ribosea 524 
             N-acetylglucosaminidase activityb 
             (nmol/min/OD) 
Strains Glucose Ribose 
Whole cells   
   BL23 (WT) 0.223 ± 0.015 2.962 ± 0.011 
   BL380 (bnaG)     0.0 ± 0.013               0.0 ± 0.015 
Supernatants   
   BL23 (WT) 0.247 ± 0.003 0.934 ± 0.075 
   BL380 (bnaG)            0.0 ± 0.0               0.0 ± 0.0 
 525 
aN-acetylglucosaminidase activity was determined with 4-nitrophenyl-526 
β-D-glucosaminide as the substrate. 527 
bEach value represents the mean of four different measurements ± 528 
standard deviation.   529 
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TABLE 3. Activity and characterization of enzyme BnaG 530 
Substratea (Structure) Activityb
4-NP-N-acetyl-β-D-glucosaminide       + 
2-NP-β-D-galactopyranoside       +/- 
4-NP-β-D-glucopyranoside        - 
2-NP-1-thio-β-D-galactopyranoside       -
4-NP-β-D-glucuronide,        -
4-NP-α-D-glucopyranoside       -
4-NP-α-D- galactopyranoside       -
4-NP-α-L- fucopyranoside       -
Lacto-N-triose (GlcNAcβ1-3Galβ1-4Glc)       + 
3’-N-Acetylglucosaminyl-Man (GlcNAcβ1-3Man)       + 
3’-N-Acetylgalactosaminyl-Gal (GalNAcβ1-3Gal)       + 
Galacto-N-biose (Galβ1-3GalNAc)       +/- 
Lacto-N-biose (Galβ1-3GlcNAc)       +/- 
Lacto-N-tetraose (Galβ1-3GlcNAcβ1-3Galβ1-4Glc)       - 
Lacto-N-neotetraose (Galβ1-4GlcNAcβ1-3Galβ1-4Glc)        - 
6’-Galactopyranosyl-GlcNAc (Galβ1-6GlcNAc)       - 
4’-Mannopyranosyl-GlcNAc (Manβ1-4GlcNAc)       -
4’-Galactofuranosyl-GlcNAc (Galβ1-4GlcNAc)       -
Lactose (Galβ1-4Glc)       -
N-acetyl-lactosamine (Galβ1-4GlcNAc)       -
Lactulose (Galβ1-4Fru)       -
Maltose (Glcα1-4Glc)       -
Maltotriose (Glcα1-4Glcα1-4Glc)       -
Characterizationc 
Vmax (μmol (mg protein/min)    33.3 
Km (mM)      2.3 
Optimal pH      6.5 
Optimal temperature (ºC)       53 
aCarbohydrates used as substrates. NP, nitrophenyl; Glc, glucose; Gal, 531 
Galactose; GlcNAc, N-acetylglucosamine; GalNAc, N-acetylgalactosamine; 532 
Man, mannose; Fru, fructose. 533 
b+, substrate is totally hydrolyzed after 16 h reaction in the conditions described 534 
in the “Materials and methods” section; +/-, substrate is partially hydrolyzed 535 
after 16 h reaction in the conditions described in the “Materials and methods” 536 
section; -, no activity detected. 537 
cThe enzyme activity was determined with 4-nitrophenyl-β-D-glucosaminide as 538 
the substrate.   539 
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FIGURE LEGENDS 540 
 541 
FIG. 1. (A) Schematic presentation of the 11.2 kbp Lactobacillus casei BL23 DNA 542 
fragment containing the β-N-acetylglucosaminidase precursor and a mannose-6P 543 
isomerase in the surroundings of the galacto-N-biose (gnb) operon (18). The first 544 
(gnbR) and last (gnbA) genes of this operon are represented. (B) Schematic 545 
presentation of proposed pathways for Lacto-N-triose and 3’-N-Acetylglucosaminyl-546 
mannose metabolism in L. casei BL23. PTS: phosphoenolpyruvate: 547 
phosphotransferase system; GlcNAc: N-acetylglucosamine; Gal: galactose; Man: 548 
mannose; LacG: phospho-β-galactosidase; NagA: N-acetylglucosamine-6P 549 
deacetylase; NagB: glucosamine-6P deaminase 550 
 551 
FIG. 2. Coomasie brilliant blue stained 10% SDS-PAGE showing the His-tagged 552 
proteins β-N-acetylglucosaminidase BnaG and mannose-6P isomerase ManA. P 553 
indicates protein standards and the numbers on the right are the molecular weights. 554 
 555 
FIG. 3. (A) Growth curves of Lactobacillus casei wild type strain BL23 on MRS basal 556 
medium without carbon source (black), with lacto-N-triose (red), 3’-N-557 
Acetylglucosaminyl-mannose (blue), 3’-N-Acetylgalactosaminyl-galactose (dark cyan) 558 
or lactose (green). (B) Growth curves of L. casei mutant strain BL380 (bnaG) on MRS 559 
basal medium without carbon source (black), with lacto-N-triose (red), 3’-N-560 
Acetylglucosaminyl-mannose (blue) or lactose (green). Data presented are mean 561 
values based on at least three replicates. Error bars indicate standard deviations. 562 
 563 
FIG. 4. Growth curves of Lactobacillus casei wild type strain BL23 (A) and L. casei 564 
mutant strain BL381 (manA) (B) on MRS basal medium without carbon source (black), 565 
 26 
 
with 3’-N-Acetylglucosaminyl-mannose (blue) or mannose (pink). Data presented are 566 
mean values based on at least three replicates. Error bars indicate standard deviations. 567 
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